Results 221 to 230 of about 83,092 (356)
Cancer pain: current practice and emerging targets
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye +5 more
wiley +1 more source
Host GPCR-cAMP signaling balances Gαs and Gαi activity to control intracellular <i>Brucella</i> infection. [PDF]
Kang Y-S, Kirby JE.
europepmc +1 more source
Confrontational Dynamics of a GPCR Revealed by Single Molecule FRET [PDF]
Reza Vafabakhsh +2 more
openalex +1 more source
Reshaping the Yeast Galactose Regulon via GPCR Signaling Cascade
Cong Fan, Jifeng Yuan
openalex +1 more source
Abstract Background and Purpose New synthetic cannabinoid receptor agonists (SCRAs) are associated with severe adverse effects, including unexpected psychiatric symptoms. These compounds are mainly active through their potent agonism on the cannabinoid receptors CB1 and CB2.
Giorgia Corli +8 more
wiley +1 more source
A negative survival pressure selection system enables GPCR antagonist screening. [PDF]
Xu T +10 more
europepmc +1 more source
Real-time visualization of ligand-specific conformational dynamics of GPCR C-terminal domain in living cells [PDF]
Zhao Lin +10 more
openalex +1 more source
Abstract Background A drug designed for a specific target often interacts with multiple targets, either unintentionally or as part of its intended mechanism of action. This has been called pharmacological pleiotropy or polypharmacology. There are key endogenous ligands such as ATP, GABA and glutamate that act on various proteins in humans. Furthermore,
Hampus Ljunggren +8 more
wiley +1 more source
Novel roles of GPCRs in the renal collecting duct. [PDF]
Kui MK, Zhang JJ, Pluznick JL.
europepmc +1 more source

